EYE 0.00% 22.0¢ nova eye medical limited

Nova Eye Medical (EYE) Discussion, page-2695

  1. 15,472 Posts.
    lightbulb Created with Sketch. 3932
    @elpassive

    I think it is quite likely we could see this. Not only would the price have to double with revenue to maintain the same valuation multiple, but we would likely see a jump from the very small valuation currently being applied (EV around 2x revenue), to a much higher multiple more suitable for a growth stock (8-10x). So that would be 2x for the sales growth alone, and then another 4-5x increase on top of that to get this to a more appropriate valuation multiple. If they announce profitability at the same time, which is quite likely given that they are predicting cash flow positive by FY25, that would likely give the share price an extra bump in addition to all of that as well. That's what happens when you have a stock valued at only $50m, the rerates can happen very quick and can be very large. As it increases in size the rerate only speeds up, as larger investors gain access to it and quickly join other investors in taking positions.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $50.34M
Open High Low Value Volume
22.5¢ 22.5¢ 21.0¢ $95.62K 444.6K

Buyers (Bids)

No. Vol. Price($)
3 52740 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 73205 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.